申请人:AJINOMOTO CO., INC.
公开号:US20020133005A1
公开(公告)日:2002-09-19
The present invention provides an AP-1 activation inhibitor, a NF-kappaB activation inhibitor, an inflammatory cytokine production inhibitor, a production inhibitor for matrix metalloprotease or an inflammatory cell adhesion factor expression inhibitor, which contains a heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient.
本发明提供了一种AP-1激活抑制剂、一种NF-kappaB激活抑制剂、一种炎症细胞因子产生抑制剂、一种基质金属蛋白酶产生抑制剂或一种炎症细胞黏附因子表达抑制剂,其包含一种杂环化合物或其药用可接受的盐作为活性成分。